Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Darentang No. 2 Pharmaceutical Factory is a specialized manufacturer of Traditional Chinese Medicine (TCM) based in Tianjin, China. It operates as a key production unit under the Tianjin Pharmaceutical Da Ren Tang Group, a company with a heritage dating back to 1914. The factory is most famous for its flagship product, Suxiao Jiuxin Wan, which is a staple emergency medication for coronary heart disease and angina in China. Its product portfolio includes a wide range of herbal formulations in various dosage forms such as pills, tablets, and capsules, focusing on cardiovascular, respiratory, and digestive health. The facility adheres to modern Good Manufacturing Practice (GMP) standards while preserving traditional processing techniques. Through its parent company, it contributes to the modernization of TCM through clinical research and standardized production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Darentang No. 2 Pharmaceutical Factory.